Method
This study was conducted according to ethical standards of clinical
e-research in Canada and in accordance with the Helsinki declaration.
This is a retrospective analysis of clinical, biological, and
echocardiographic data prospectively collected in a single center
registry of all patients (n=157) who underwent percutaneous LAAC using
WN devices at our institution from October 2016 to October 2021.
Combined strategy was defined as a LAAC closure with WN devices
associated with concomitant cardiac structural or electrophysiological
interventions using the same femoral venous access.